Bronchogenic carcinoma in solid organ transplant recipients

Ahmed Z, Marshall MB, Kucharczuk JC, et al.: Lung cancer in transplant recipients. Arch Surg 2004, 139:902–906.

Penn I: Post transplant malignancies. Transplant Proc 1999, 31:1260–1266.

Kim MS, Kim SI, Kim YS, et al.: De novo cancer in transplant recipients. Transplant Proc 1996, 28:1652–1655.

Vallejo GH, Romero CJ, deVicente JC: Incidence and risk factors for cancer after liver transplantation. Crit Rev Oncol Hematol 2005, 56:87–99. This comprehensive review identified neoplastic complications of liver transplantation and the lack of association between liver transplantation and bronchogenic carcinoma.

Penn I: Tumors after renal and cardiac transplantation. Hematol Oncol Clin North Am 1993, 7:431–445. This review highlights and compares the neoplastic complications of multiple large renal transplant registries.

Pham SM, Kormos RL, Landrenau RJ, et al.: Solid tumors after heart transplantation: lethality of lung cancer. Ann Thorac Surg 1995, 60:1783–1789.

Goldstein DJ, Williams DL, Oz MC, et al.: De novo malignancies after cardiac transplantation. Ann Thorac Surg 1995, 60:1783–1789.

Collins J, Kazerooni EA, Lacomis J, et al.: Bronchogenic carcinoma after lung transplantation. Frequency, clinical characteristics, and imaging findings. Radiology 2002, 224:131–138. Multicenter study aimed at identifying radiologic findings and clinical manifestations of lung cancer in lung transplant recipients.

Flemming RH, Jennison SH, Naunheim KS: Primary bronchogenic carcinoma in the heart transplant recipient. Ann Thorac Surg 1994, 57:1300–1301.

Curtil A, Robin J, Tronc F, et al.: Malignant neoplasms following cardiac transplantation. Eur J Cardiothrac Surg 1997, 12:101–106.

Delcambre F, Purvot FR, Ramon P, et al.: Primary bronchogenic carcinoma in transplant recipients. Transplant Proc 1996, 28:2884–2885.

Sone S, Takashima S, Li F, et al.: Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet 1998, 351:1242–1245.

Henschke CI, McCauley DI, Yankelevitz DF, et al.: Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999, 354:99–105.

DePerrot M, Wigle DA, Pierre AF, et al.: Bronchogenic carcinoma after solid organ transplantation. Ann Thorac Surg 2003, 75:367–371.

Tanigushi S, Cooper DK, Chaffin JS, et al.: Primary bronchogenic carcinoma in recipients of heart transplants. Transpl Int 1997, 10:312–316.

Mihalov ML, Gattuso P, Abraham K, et al.: Incidence of post transplant among 674 solid-organ transplant recipients at a single center. Clin Transplant 1996, 10:248–255.

Pedotti P, Cardiloo M, Rossini G, et al.: Incidence of cancer after kidney transplant: results from North Italy transplant program. Transplantation 2003, 76:1448–1451.

Anyanwu AC, Townsend ER, Banner NR, et al.: Primary lung carcinoma after heart or lung transplantation: management and outcome. J Heart Lung Transplant 2001, 20:1044–1053. Retrospective cohort illustrating risk factors for developing bronchogenic carcinoma, effects of immunosuppression, and treatment of lung cancer in heart transplant recipients.

Dorent R, Mohammandi S, Tezenas S, et al.: Lung cancer in heart transplant patients: a 16-year survey. Transplant Proc 2000, 32:2752–2754.

Arcasoy SM, Hersch C, Christie JD, et al.: Bronchogenic carcinoma complicating lung transplantation. J Heart Lung Transplant 2001, 20:1044–1053.

Hojo M, Takashi M, Maluccio M, et al.: Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 1999, 397:530–535. In vitro demonstration of tumor transformation and progression after cellular exposure to cyclosporine.

McAdams HP, Erasmus JJ, Palmer SM: Complications (excluding hyperinflation) involving the native lung after single lung transplantation: incidence, radiologic features, and clinical importance. Radiology 2001, 218:233–241.

Hamarti LB, Schulman LL, Austin JH: Lung nodules and masses after cardiac transplantation. Radiology 1993, 188:491–497.

Tollerud DJ, Clark JW, Brown LM, et al.: Association of cigarette smoking with decreased numbers of circulating natural killer cells. Am Rev Respir Dis 1989, 139:194–198.

Heelan RT, Flehinger BJ, Melamed MR: Non-small cell lung cancer: results of the New York screening program. Radiology 1984, 151:289–293.

Muhm JR, Miller WE, Fontana RS, et al.: Lung cancer detected during a screening program using four-month chest radiographs. Radiology 1983, 148:609–615.

Choi YH, Leung AN, Miro S, et al.: Primary bronchogenic carcinoma after heart or lung transplantation: radiologic and clinical findings. J Thorac Imaging 2000, 15:36–40.

Kazerooni EA, Chow LC, Whyte RI, et al.: Preoperative examination of lung transplant candidates: value of chest CT compared with chest radiography. AJR Am J Roentgenol 1995, 165:1343–1348.

Kehinde EO, Petermann A, Morgan JD, et al.: Triple therapy and incidence of de novo cancer in renal transplant recipients. Br J Surg 1994, 81:985–986.

Jonas S, Rayes N, Neumann U, et al.: De novo malignancies after liver transplantation using tacrolimusbased protocols or cyclosporine-based quadruple immunosuppresssion with an interleukin 2 receptor antibody or antithymocyte globulin. Cancer 1997, 80:1140–1150.

Frezza EE, Fung JJ, van Thiel DH: Non lymphoid cancer after liver transplantation. Hepatogastroenterology 1997, 44:1172–1181.

Haagsma EB, Hagens VE, Schaapveld M, et al.: Increased cancer risk after liver transplantation: a populationbased study. J Hepatol 2001, 34:84–91.

Kelly DM, Sukru E, Stephen RG, et al.: Liver transplant recipients are not at increased risk for non-lymphoid solid organ tumors. Cancer 1998, 83:1237–1243.

Berringuer M, Prieto M, Bustamante M, et al.: Incidence of de novo neoplasms after liver transplantation. Med Clin 1998, 111:481–484.

Peyregene V, Ducerf C, Admam M, et al.: De novo cancer after orthotopic liver transplantation. Transplant Proc 1998, 30:1484–1485.

Jain AB, Yee LD, Nalesnik MA, et al.: Comparative incidence of de novo non-lymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation 1998, 66:1193–1200.

Sanchez EQ, Marubashi S, Jung G, et al.: De novo tumors after liver transplantation: a single-institution experience. Liver Tranpl 2002, 8:285–291.

Xiol X, Guardiola J, Menindez S, et al.: Risk factors for development of de novo neoplasia after liver transplantation. Liver Tranpl 2001, 7:971–975.

Benlloch S, Berringuer M, Prieto M, et al.: De novo internal neoplasms after liver transplantation: increased risk and aggressive behavior in recent years. Am J Transplant 2004, 4:596–604.

Briceno J, Lopez-Cillero P, Fraga E, et al.: Results of liver transplantation in a Spanish group: a report from the Cordoba unit. Clin Transpl 2001, 15:187–194.

Jaurrieta E, Casais L, Figueras J, et al.: Analysis of 500 liver transplantations at Bellvitge Hospital. Med Clin 2000, 115:521–529.

Bellamy CO, DiMartini AM, Ruppert K, et al.: Liver transplantation or alcoholic cirrhosis: long term follow-up and impact of disease occurrence. Transplantation 2001, 72:619–626.

Jimenez C, Rodriguez D, Marques E, et al.: De novo tumors after orthotopic liver transplantation. Transplant Proc 2002, 34:297–298.

Levy M, Backman L, Husberg B, et al.: De novo malignancy following liver transplantation: a single center study. Transplant Proc 1993, 25:1397–1399.

Schmilovitz-Weiss H, Mor E, Sulkes J, et al.: De novo tumors after liver transplantation: a single-center experience. Transplant Proc 2003, 35:665–666.